The effects of tislelizumab plus chemotherapy as first-line treatment on health-related quality of life of patients with advanced squamous non-small cell lung cancer: Results from a phase 3 randomized clinical trial
Author:
Funder
BeiGene
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference28 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin,2018
2. Cancer statistics in China, 2015;Chen;CA Cancer J. Clin,2016
3. Global Cancer Observatory: Cancer Today;Ferlay,2020
4. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany;Iyer;Lung Cancer,2013
5. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N. Engl. J. Med,2002
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The safety and efficacy of tislelizumab, alone or in combination with chemotherapy, for the treatment of non-small cell lung cancer: a systematic review of clinical trials;BMC Pulmonary Medicine;2023-12-08
2. Tislelizumab in advanced/metastatic esophageal squamous cell carcinoma: health-related quality of life in Asian patients;Current Medical Research and Opinion;2023-11-23
3. Symptom Clusters and Quality of Life in Patients With Lung Cancer Receiving Immunotherapy in China;2023-11-01
4. Safety and efficacy of tislelizumab plus chemotherapy as preoperative treatment in potentially resectable locally advanced non-small-cell lung cancer patients;Interdisciplinary CardioVascular and Thoracic Surgery;2023-09-19
5. The effects of tislelizumab treatment on the health‐related quality of life of patients with advanced non‐small cell lung cancer;Cancer Medicine;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3